Sponsor or institution

Clinical trials and research at Xijing Hospital of Digestive Diseases

• 28Clinical trials
• 1New in 30 days
• 1Country

Newest trials

All recruiting trials (28)

• Dual-drug therapy with linlarase glutarate and amoxicillin vs bismuth quadruple therapy for first-line Helicobacter pylori eradication

  This trial tests whether a dual-drug regimen of linlarase glutarate capsules plus amoxicillin can match the effectiveness of a standard bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication.

  Recruiting at 24 sites Phase 4 Xijing Hospital of Digestive Diseases · Zhengzhou, Henan and 23 other locations · NCT07897994

• Active video education by disease subtype to improve bowel prep before colonoscopy

  We’re testing whether adding subtype-specific video education to standard prep improves bowel cleanliness in adults with IBD undergoing colonoscopy.

  Recruiting at 12 sites Xijing Hospital of Digestive Diseases · Beijing, BeijingBeijing and 11 other locations · NCT07582731

• Upadacitinib versus infliximab for second-line treatment of acute severe ulcerative colitis

  This trial will see if upadacitinib or infliximab works better to induce remission in adults with acute severe ulcerative colitis who need second-line therapy.

  Recruiting at 4 sites Phase 4 Xijing Hospital of Digestive Diseases · Ankang, Shaanxi and 3 other locations · NCT07550673

• Upadacitinib versus corticosteroids for first-line treatment of acute severe ulcerative colitis

  This test will see if upadacitinib works as well as corticosteroids to induce remission in adults with acute severe ulcerative colitis.

  Recruiting at 4 sites Phase 4 Xijing Hospital of Digestive Diseases · Ankang, Shaanxi and 3 other locations · NCT07546097

• Microplastic exposure and progression of stomach precancerous changes

  This project will test if adults with higher microplastic exposure are more likely to have precancerous stomach changes or gastric cancer.

  Recruiting Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT07542652

• Impact of full-time RDI on major adverse events and procedure time during endoscopic submucosal dissection for early gastric cancer or gastric adenoma

  This study tests whether using Red Dichromatic Imaging (RDI) during endoscopic submucosal dissection (ESD) can reduce major adverse events and shorten procedure time for adults with early gastric cancer or gastric adenoma.

  Recruiting Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT07401303

• Optimizing ear-based vagus nerve stimulation for hard-to-treat constipation

  This trial will test whether gentle electrical stimulation of the ear (taVNS) twice daily for 20 days helps adults with refractory constipation have more complete spontaneous bowel movements and reduces laxative use.

  Recruiting Xijing Hospital of Digestive Diseases · Xi'an · NCT07344402

• Brain stimulation (tACS) for adults with stubborn constipation and somatic symptom disorder

  We will test whether four weeks of gentle brain stimulation (tACS) can improve bowel movements and symptoms in adults with refractory functional constipation and somatic symptom disorder.

  Recruiting at 2 sites Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi and 1 other locations · NCT07323407

• Fenofibrate versus UDCA for first-line treatment of primary biliary cholangitis

  This study will test whether fenofibrate works better than the standard medicine UDCA for adults with newly diagnosed primary biliary cholangitis who have not been treated before.

  Recruiting at 2 sites Phase 3 Xijing Hospital of Digestive Diseases · Guangzhou, Guangdong and 1 other locations · NCT07296458

• Clostridium butyricum for anxiety and depression in functional dyspepsia

  This trial will test whether taking the probiotic Clostridium butyricum for four weeks can reduce anxiety and depression symptoms in adults with functional dyspepsia.

  Recruiting Phase 4 Xijing Hospital of Digestive Diseases · Xi’an, Shanxi · NCT07182890

• Adding Saccharomyces boulardii to bismuth quadruple therapy for H. pylori rescue

  This tests whether adding the probiotic Saccharomyces boulardii to bismuth-containing quadruple therapy helps adults whose H. pylori infection did not clear after prior treatments.

  Recruiting Phase 4 Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT07139366

• Vonoprazan plus different antibiotics to clear H. pylori infection

  This trial will test whether vonoprazan paired with different antibiotic combinations can clear H. pylori in adults who have never had eradication treatment.

  Recruiting Phase 4 Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT07068607

• First-line biologic choice for moderate-to-severe ulcerative colitis: infliximab versus vedolizumab

  This will test whether infliximab or vedolizumab works better as the first biologic for adults aged 18–70 with moderate-to-severe ulcerative colitis.

  Recruiting Xijing Hospital of Digestive Diseases · Shanxi, Xi'an · NCT06962020

• 3D imaging during colonoscopy to find high-risk adenomas

  This trial tests whether a 3D imaging device used during colonoscopy helps identify patients with high-risk adenomas better than standard 2D imaging.

  Recruiting Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT06924489

• Evaluating Sintilimab and Bevacizumab for Rectal Cancer Treatment

  This study is testing if a new combination of two drugs, sintilimab and bevacizumab, can improve treatment outcomes for people with rectal cancer who have had different previous therapies.

  Recruiting Phase 2 Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT06808412

• Using Fenofibrate with Ursodeoxycholic Acid for Primary Biliary Cholangitis

  This study is testing whether combining fenofibrate with ursodeoxycholic acid is safe and helpful for people with Primary Biliary Cholangitis who have taken part in a related study before.

  Recruiting Phase 3 Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT06755541

• Using Fenofibrate with Ursodeoxycholic Acid for Primary Biliary Cholangitis

  This study is testing if taking fenofibrate with ursodeoxycholic acid can be safe and helpful for people with Primary Biliary Cholangitis who have already been part of a related study.

  Recruiting Phase 3 Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT06755151

• Thalidomide combined with glutamine for radiation intestinal injury

  This project will test whether thalidomide plus glutamine can reduce intestinal bleeding in adults with radiation enteritis.

  Recruiting Phase 2 Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT06617182

• Ursodeoxycholic acid for reversing gastric intestinal metaplasia

  This study will test whether taking ursodeoxycholic acid for six months can reverse gastric intestinal metaplasia in adults who do not have Helicobacter pylori infection.

  Recruiting at 6 sites Phase 4 Xijing Hospital of Digestive Diseases · Pingdingshan, Henan and 5 other locations · NCT06610760

• Weifuchun tablets versus folic acid to reverse gastric intestinal metaplasia

  This trial tries to see if taking Weifuchun tablets daily for six months can reverse gastric intestinal metaplasia in adults without Helicobacter pylori compared with daily folic acid.

  Recruiting at 9 sites Phase 4 Xijing Hospital of Digestive Diseases · Ankang and 8 other locations · NCT06610266

• Using Fenofibrate to treat Primary Biliary Cholangitis

  This study tests if Fenofibrate can safely help people with Primary Biliary Cholangitis manage their liver condition over a long time.

  Recruiting Phase 2/3 Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT06365424

• Comparing one-person and two-person techniques in single-balloon enteroscopy

  This study is testing whether one doctor can do a small bowel procedure more effectively and comfortably for patients than two doctors working together.

  Recruiting at 6 sites Xijing Hospital of Digestive Diseases · Lanzhou, Gansu and 5 other locations · NCT06280469

• Evaluating brain connectivity in patients with refractory constipation

  This study is trying to see how brain activity in people with stubborn constipation can help predict if they will respond well to fluoxetine and other treatments.

  Recruiting at 3 sites Xijing Hospital of Digestive Diseases · Yinchuan, Ningxia and 2 other locations · NCT06221722

• Improving patient compliance with endoscopic surveillance after ESD using questionnaires and feedback

  This study is trying to see if giving patients who had endoscopic surgery for mucosal lesions a questionnaire and feedback about their follow-up care can help them stick to their post-surgery check-ups better.

  Recruiting Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT06092281

• Combining fenofibrate with ursodeoxycholic acid for treating primary biliary cholangitis

  This study is testing if adding fenofibrate to the usual treatment with ursodeoxycholic acid can help people with primary biliary cholangitis who aren't getting better with just ursodeoxycholic acid.

  Recruiting at 6 sites Phase 3 Xijing Hospital of Digestive Diseases · Lanzhou, Gansu and 6 other locations · NCT05751967

• Fenofibrate treatment for patients with compensated cirrhosis and primary biliary cholangitis

  This study is testing if fenofibrate can help people with compensated cirrhosis caused by primary biliary cholangitis feel better when added to their current treatment.

  Recruiting at 11 sites Phase 2/3 Xijing Hospital of Digestive Diseases · Beijing, Beijing Municipality and 11 other locations · NCT05749822

• Comparing surgical methods for Siewert Type II adenocarcinoma at the esophagogastric junction

  This study is testing two different surgical methods to see which one works better and is safer for people with Siewert Type II adenocarcinoma at the esophagogastric junction.

  Recruiting Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT05356520

• Fenofibrate added to UDCA for people with primary biliary cirrhosis not fully responding to UDCA

  This trial tests adding fenofibrate to UDCA for adults with primary biliary cirrhosis who did not fully respond to UDCA alone.

  Recruiting Phase 3 Xijing Hospital of Digestive Diseases · Xi'an, Shaanxi · NCT02823366

Quick answers

How many clinical trials run by Xijing Hospital of Digestive Diseases are recruiting right now?

28, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 8, Phase 3: 5, Phase 2: 2, Phase 2/3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →